Can Destroying Senescent Cells Treat Age-Related Disease? (March 1, 2020)
Our mission is to extend human healthspan, the period in one’s life unburdened by the diseases of aging.
Working at the frontier of biotechnology and medicine, UNITY’s goal is to halt, slow or reverse age-related diseases, while restoring human health.
Management
Members of UNITY’s management team have collectively advanced nearly 100 therapeutic candidates into human clinical trials and are responsible for 13 FDA-approved medicines.
ANIRVAN GHOSH, Ph.D.
Chief Executive Officer
NATHANIEL DAVID, Ph.D.
Co-Founder and President
DAN MARQUESS, D. Phil
Chief Scientific Officer
JAMIE DANANBERG, M.D.
Chief Medical Officer
LYNNE SULLIVAN
Chief Financial Officer
SUSAN LUNDEEN
Senior Vice President of People
DOUGLAS RICH
Senior Vice President of Operations
CAMILLE LANDIS
Senior Vice President of Corporate Development
BOARD OF DIRECTORS
PAUL L. BERNS
Former President and Chief Executive Officer,
Anacor Pharmaceuticals, Inc.
KRISTINA BUROW
Managing Director,
ARCH Venture Partners
GRAHAM COOPER
Former CFO and COO, Assembly Biosciences, Inc.
Former CFO, Receptos, Inc.,
Assembly Biosciences, Inc.
NATHANIEL DAVID, PH.D.
Co-Founder and President,
UNITY Biotechnology
ANIRVAN GHOSH
Chief Executive Officer,
UNITY Biotechnology
DAVID LACEY, M.D.
Former Senior Vice President of Research,
Amgen
KEITH R. LEONARD JR.
Chairman,
UNITY Biotechnology
ROBERT T. NELSEN
Co-Founder and Managing Director,
ARCH Venture Partners
MARGO ROBERTS, PH.D.
Former Chief Scientific Officer,
Kite Pharma, Inc.
CAMILLE SAMUELS
Partner,
Venrock
FOUNDERS
NATHANIEL DAVID, Ph.D.
President
JAN VAN DEURSEN, Ph.D.
JUDITH “JUDY” CAMPISI, Ph.D.
Professor at the Buck Institute for Research on Aging; Senior Scientist at Lawrence Berkeley National Laboratory
DAOHONG ZHOU, M.D.
Professor of Pharmacodynamics and Radiation Oncology, University of Florida at Gainesville
Can Destroying Senescent Cells Treat Age-Related Disease? (March 1, 2020)
10 Breakthrough Technologies (February 26, 2020)
